日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

您現在的位置: > Language Tips > Audio & Video > Special Speed News  
 





 
A one-pill answer to treating H.I.V.
[ 2006-07-27 09:43 ]

This is the VOA Special English Health Report.

The first treatment for H.I.V. in the form of one pill taken once a day is going to market in the United States. A spokesman for the drug company Bristol-Myers Squibb says the new product, called Atripla, has already been shipped to suppliers.

Atripla is the result of some unusual cooperation among drug companies. The government approved the treatment on July twelfth. Food and Drug Administration officials had until October to make a decision. But they acted quickly.

Doctors believe a one-pill-a-day plan will be more successful than current treatments which can involve several pills a day. Patients are less likely to miss treatments. Missed treatments can help the virus gain resistance to drugs.

Atripla combines three medicines widely used to treat the most common form of H.I.V., the virus that causes AIDS. One of the three is Sustiva, made by Bristol-Myers. The other two are Viread and Emtriva, both from Gilead Sciences.

The new tablets are approved for use alone or with other antiretroviral products to treat adults.

Earlier this year, the New England Journal of Medicine published a study of Atripla. Gilead paid for the study. Researchers compared the effectiveness of Atripla to the widely used combination of Sustiva and Combivir, from GlaxoSmithKline.

They reported that Atripla suppressed virus levels in more patients and with fewer side effects. A one-month supply in the United States will cost more than one thousand dollars, the same price as for the separate drugs it contains.

Gilead and Bristol-Myers will jointly market Atripla. AIDS activists praised the cooperation between drug makers as historic. They also called on them to provide the treatment to developing nations.

The Bristol-Myers spokesman says his company and Gilead want to do that. They are currently negotiating with Merck. That company has rights to market the active substance in Sustiva in a number of countries outside the United States.

The spokesman says the new product could be offered as early as September through the President's Emergency Plan for AIDS Relief. The plan provides drugs to fifteen poor countries, mostly in Africa. The Food and Drug Administration recently approved a two-pill-a-day H.I.V. treatment for use under the emergency plan.

And that's the VOA Special English Health Report, written by Caty Weaver. Transcripts and archives of our reports are at voaspecialenglish.com. I'm Barbara Klein.  

(來源:VOA   英語點津姍姍編輯)

 
 

 

 

 
 

48小時內最熱門

     

本頻道最新推薦

     
  Rains help ease crop worries in U.S. corn belt
  Google profits soar in 2nd quarter
  清涼海風:Talk of the town
  Former US congressional leaders urge reform
  Make beautiful music under the stars at Ravinia






主站蜘蛛池模板: 一区二区三区四区视频 | 深夜爽爽爽gif福利免费 | 挑战者联盟第一季免费观看完整版 | www.尤物视频.com | 午夜性刺激在线观看视频 | 亚洲日本高清成人aⅴ片 | 亚洲毛片在线观看 | 日韩在线免费观看视频 | 四虎精品8848ys一区二区 | 91欧美国产| av色站 | 欧美日韩国产一区二区三区不卡 | 日本中文字幕视频 | 久久久国产精品 | 狠狠五月 | 蜜桃视频在线观看免费视频网站www | 日韩成人在线电影 | 免费一级在线 | 陈宝莲a毛片在线播放 | 182tv在线观看国产路线一 | 欧美综合视频在线 | 草草免费观看视频在线 | A片欧美乱妇高特黄AA片片 | 久操伊人| 天天摸天天碰成人免费视频 | 亚洲国产婷婷香蕉久久久久久99 | 亚洲欧美另类日韩 | 999av视频| 一区二区三区高清 | 91高清在线观看 | 色拍拍欧美视频在线看 | 日本不卡在线观看免费v | www.欧美在线 | 浮力国产第一页 | 99精品在线免费 | www.国产高清 | 日韩一区二区在线观看视频 | 欧美精品欧美精品系列 | 性夜影院爽黄e爽痛轻点www | 日韩高清免费在线观看 | 最近最新中文字幕 |